Finansiella nyckeltal InnoCan Pharma Corporation

Aktier

INNO

CA45783P5085

Farmaceutiska produkter

Fördröjd Canadian Securities Exchange Andra börsplatser 19.44.26 2026-06-10			5-dagars förändring	Förändring 1 jan.
3,600 ^CAD	0,00 %		+5,88 %	−46,27 %

05-27	InnoCan Pharma Corporation redovisar resultat för det första kvartalet som avslutades den 31 mars 2026	CI
05-06	Innocan Pharma Corporation uppmärksammas i Pain Medicine News för sin liposomala plattform för syntetisk cannabidiol	CI

a.4Nu-7i4q-AlxNgD2KIqw02N_lS65Pnqi3X2jeF0fQLI.iJ7ZrxptiEVFRzCHf_Pk6zoUzRqMTEORthLpIRlQKcq2hPOEGn-uQzxwbw

Publicerade finansiella data: INNOCAN PHARMA CORPORATION

Årlig

Kvartalsvis

Halvårsvis

YTD

LTM

Skatteperiod: December	2021	2022	2023	2024	2025
Revenues	196 tn	2,56 mn	13,66 mn	29,44 mn	26,61 mn
Total Revenues	196 tn	2,56 mn	13,66 mn	29,44 mn	26,61 mn
Cost of Goods Sold, Total	75 tn	452 tn	1,68 mn	3,25 mn	2,68 mn
Gross Profit	121 tn	2,11 mn	11,98 mn	26,19 mn	23,93 mn
Selling General & Admin Expenses, Total	6,2 mn	6,85 mn	13,98 mn	25,88 mn	24,25 mn
R&D Expenses	1,4 mn	1,53 mn	1,8 mn	1,55 mn	932 tn
Other Operating Expenses, Total	7,6 mn	8,37 mn	15,78 mn	27,43 mn	25,19 mn
Operating Income	−7,48 mn	−6,27 mn	−3,8 mn	−1,25 mn	−1,26 mn
Interest Expense, Total	−13 tn	−2 tn	-	−7 tn	−3 tn
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	−13 tn	−2 tn	-	−7 tn	−3 tn
Currency Exchange Gains (Loss)	−290 tn	−415 tn	4 tn	−42 tn	30 tn
Other Non Operating Income (Expenses)	−2,31 mn	2,8 mn	−235 tn	2,22 mn	1,6 mn
EBT, Excl. Unusual Items	−10,09 mn	−3,89 mn	−4,03 mn	919 tn	375 tn
Other Unusual Items	-	-	-	-	−290 tn
EBT, Incl. Unusual Items	−10,09 mn	−3,89 mn	−4,03 mn	919 tn	85 tn
Income Tax Expense	-	1 tn	214 tn	1,18 mn	426 tn
Earnings From Continuing Operations	−10,09 mn	−3,89 mn	−4,25 mn	−262 tn	−341 tn
Net Income to Company	−10,09 mn	−3,89 mn	−4,25 mn	−262 tn	−341 tn
Minority Interest	44 tn	125 tn	−452 tn	−1,57 mn	−783 tn
Net Income - (IS)	−10,05 mn	−3,76 mn	−4,7 mn	−1,83 mn	−1,12 mn
Net Income to Common Incl Extra Items	−10,05 mn	−3,76 mn	−4,7 mn	−1,83 mn	−1,12 mn
Net Income to Common Excl. Extra Items	−10,05 mn	−3,76 mn	−4,7 mn	−1,83 mn	−1,12 mn
Per aktie poster
Net EPS - Basic	−2,91	−0,98	−1,19	−0,43	−0,25
Basic EPS - Continuing Operations	−2,91	−0,98	−1,19	−0,43	−0,25
Basic Weighted Average Shares Outstanding	3,45 mn	3,83 mn	3,95 mn	4,31 mn	4,48 mn
Net EPS - Diluted	−2,91	−0,98	−1,19	−0,43	−0,25
Diluted EPS - Continuing Operations	−2,91	−0,98	−1,19	−0,43	−0,25
Diluted Weighted Average Shares Outstanding	3,45 mn	3,83 mn	3,95 mn	4,31 mn	4,48 mn
Normalized Basic EPS	−1,81	−0,6	−0,75	−0,23	−0,12
Normalized Diluted EPS	−1,81	−0,6	−0,75	−0,23	−0,12
Kompletterande punkter
EBITDA	−7,44 mn	−6,23 mn	−3,77 mn	−1,21 mn	−1,21 mn
EBITA	−7,48 mn	−6,27 mn	−3,8 mn	−1,25 mn	−1,26 mn
EBIT	−7,48 mn	−6,27 mn	−3,8 mn	−1,25 mn	−1,26 mn
Effective Tax Rate - (Ratio)	-	−0,03	−5,3	128,51	501,18
Normalized Net Income	−6,26 mn	−2,3 mn	−2,97 mn	−998 tn	−549 tn
Interest on Long-Term Debt	-	-	-	-	-
Kompletterande driftskostnadsposter
Selling and Marketing Expenses	2,5 mn	3,49 mn	10,91 mn	21,77 mn	20,67 mn
General and Administrative Expenses	3,71 mn	3,36 mn	3,08 mn	4,12 mn	3,58 mn
Research And Development Expense From Footnotes	1,4 mn	1,53 mn	1,8 mn	1,55 mn	932 tn
Stock-Based Comp., R&D Exp. (Total)	109 tn	120 tn	102 tn	250 tn	274 tn
Stock-Based Comp., S&M Exp. (Total)	490 tn	223 tn	96 tn	396 tn	296 tn
Stock-Based Comp., G&A Exp. (Total)	1,56 mn	624 tn	656 tn	1,41 mn	897 tn
Stock-Based Comp., Other (Total)	−1 tn	-	-	-	-
Total Stock-Based Compensation	2,16 mn	967 tn	854 tn	2,06 mn	1,47 mn

Skatteperiod: December	2021	2022	2023	2024	2025
TILLGÅNGAR
Cash And Equivalents	11,05 mn	4,95 mn	3,88 mn	5,01 mn	6,69 mn
Total Cash And Short Term Investments	11,05 mn	4,95 mn	3,88 mn	5,01 mn	6,69 mn
Accounts Receivable, Total	-	62 tn	249 tn	250 tn	223 tn
Other Receivables	169 tn	181 tn	445 tn	286 tn	721 tn
Total Receivables	169 tn	243 tn	694 tn	536 tn	944 tn
Inventory	510 tn	1,13 mn	1,75 mn	3,32 mn	2,18 mn
Prepaid Expenses	715 tn	453 tn	340 tn	67 tn	72 tn
Other Current Assets, Total	79 tn	104 tn	138 tn	219 tn	554 tn
Total Current Assets	12,52 mn	6,88 mn	6,8 mn	9,15 mn	10,44 mn
Net Property Plant And Equipment	54 tn	98 tn	136 tn	113 tn	86 tn
Total Assets	12,58 mn	6,98 mn	6,94 mn	9,26 mn	10,52 mn
Skulder
Accounts Payable, Total	53 tn	95 tn	112 tn	185 tn	235 tn
Accrued Expenses, Total	432 tn	318 tn	463 tn	478 tn	734 tn
Current Portion of Leases	1 tn	14 tn	22 tn	10 tn	-
Other Current Liabilities	3,08 mn	304 tn	1,95 mn	1,56 mn	386 tn
Total Current Liabilities	3,56 mn	731 tn	2,54 mn	2,24 mn	1,36 mn
Long-Term Debt	-	-	-	-	930 tn
Long-Term Leases	-	20 tn	11 tn	-	-
Total Liabilities	3,56 mn	751 tn	2,55 mn	2,24 mn	2,28 mn
Common Stock, Total	-	-	-	-	-
Additional Paid In Capital	33,66 mn	34,77 mn	37,18 mn	40,08 mn	41,63 mn
Retained Earnings	−24,61 mn	−28,37 mn	−33,07 mn	−34,91 mn	−36,03 mn
Total Common Equity	9,06 mn	6,39 mn	4,1 mn	5,17 mn	5,6 mn
Minority Interest	−44 tn	−169 tn	283 tn	1,86 mn	2,64 mn
Total Equity	9,01 mn	6,22 mn	4,39 mn	7,02 mn	8,24 mn
Total Liabilities And Equity	12,58 mn	6,98 mn	6,94 mn	9,26 mn	10,52 mn
Kompletterande objekt
ECS Total Shares Outstanding on Filing Date	3,82 mn	3,87 mn	4,32 mn	4,48 mn	4,5 mn
ECS Total Common Shares Outstanding	3,82 mn	3,84 mn	4,12 mn	4,46 mn	4,5 mn
Book Value / Share	2,37	1,66	1	1,16	1,24
Tangible Book Value	9,06 mn	6,39 mn	4,1 mn	5,17 mn	5,6 mn
Tangible Book Value Per Share	2,37	1,66	1	1,16	1,24
Total Debt	1 tn	34 tn	33 tn	10 tn	930 tn
Net Debt	−11,05 mn	−4,91 mn	−3,85 mn	−5 mn	−5,76 mn
Minority Interest, Total (Incl. Fin. Div)	−44 tn	−169 tn	283 tn	1,86 mn	2,64 mn
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	188 tn	224 tn	214 tn	184 tn	201 tn
Inventories - Work In Process, Total	-	-	-	-	193 tn
Inventories - Finished Goods, Total	322 tn	907 tn	1,53 mn	3,27 mn	1,78 mn
Full Time Employees	-	-	-	-	-
Part Time Employees	-	-	-	-	-

Skatteperiod: December	2021	2022	2023	2024	2025
Net Income	−10,05 mn	−3,76 mn	−4,7 mn	−1,83 mn	−1,12 mn
Depreciation & Amortization - CF	43 tn	35 tn	33 tn	35 tn	42 tn
Depreciation & Amortization, Total	43 tn	35 tn	33 tn	35 tn	42 tn
Stock-Based Compensation (CF)	2,16 mn	967 tn	854 tn	2,01 mn	1,46 mn
Other Operating Activities, Total	2,18 mn	−2,77 mn	702 tn	−584 tn	−1,46 mn
Change In Accounts Receivable	2 tn	−15 tn	−2 tn	17 tn	-
Change In Inventories	−79 tn	−621 tn	−616 tn	−1,57 mn	1,14 mn
Change In Accounts Payable	−474 tn	42 tn	17 tn	72 tn	50 tn
Change in Other Net Operating Assets	−418 tn	63 tn	−192 tn	278 tn	384 tn
Cash from Operations	−6,63 mn	−6,07 mn	−3,9 mn	−1,58 mn	495 tn
Capital Expenditure	−41 tn	−26 tn	−46 tn	−15 tn	−16 tn
Other Investing Activities, Total	−7 tn	−5 tn	−38 tn	69 tn	1 tn
Cash from Investing	−48 tn	−31 tn	−84 tn	54 tn	−15 tn
Long-Term Debt Issued, Total	-	-	-	-	640 tn
Total Debt Issued	-	-	-	-	640 tn
Long-Term Debt Repaid, Total	−38 tn	−11 tn	−22 tn	−22 tn	−11 tn
Total Debt Repaid	−38 tn	−11 tn	−22 tn	−22 tn	−11 tn
Issuance of Common Stock	11,92 mn	136 tn	1,56 mn	891 tn	93 tn
Other Financing Activities, Total	3,43 mn	-	1,38 mn	1,84 mn	424 tn
Cash from Financing	15,3 mn	125 tn	2,92 mn	2,7 mn	1,15 mn
Foreign Exchange Rate Adjustments	84 tn	−128 tn	9 tn	−56 tn	53 tn
Net Change in Cash	8,71 mn	−6,1 mn	−1,06 mn	1,12 mn	1,68 mn
Kompletterande punkter
Cash Income Tax Paid (Refund)	-	-	-	-	1,3 mn
Levered Free Cash Flow	−7,41 mn	−6,25 mn	−720 tn	−220 tn	224 tn
Unlevered Free Cash Flow	−7,4 mn	−6,24 mn	−720 tn	−215 tn	226 tn
Change In Net Working Capital	4,89 mn	3,3 mn	−816 tn	1,51 mn	483 tn
Net Debt Issued / Repaid	−38 tn	−11 tn	−22 tn	−22 tn	629 tn

Skatteperiod: December	2021	2022	2023	2024	2025
Lönsamhet
Return on Assets	−55,3	−40,06	−34,16	−9,62	−7,93
Return on Total Capital	−171,78	−51,29	−44,52	−13,61	−9,68
Return On Equity %	−373,46	−51,05	−80,07	−4,59	−4,47
Return on Common Equity	−368,83	−48,73	−89,55	−39,57	−20,88
Marginalanalys
Gross Profit Margin %	61,73	82,34	87,71	88,96	89,93
SG&A Margin	3,16 tn	267,57	102,4	87,93	91,14
EBITDA Margin %	−3,79 tn	−243,49	−27,6	−4,12	−4,56
EBITA Margin %	−3,82 tn	−244,86	−27,85	−4,24	−4,72
EBIT Margin %	−3,82 tn	−244,86	−27,85	−4,24	−4,72
Income From Continuing Operations Margin %	−5,15 tn	−151,97	−31,1	−0,89	−1,28
Net Income Margin %	−5,13 tn	−147,09	−34,41	−6,23	−4,22
Net Avail. For Common Margin %	−5,13 tn	−147,09	−34,41	−6,23	−4,22
Normalized Net Income Margin	−3,2 tn	−90,07	−21,77	−3,39	−2,06
Levered Free Cash Flow Margin	−3,78 tn	−244,06	−5,27	−0,75	0,84
Unlevered Free Cash Flow Margin	−3,78 tn	−244,01	−5,27	−0,73	0,85
Tillgångsomslutning
Asset Turnover	0,02	0,26	1,96	3,63	2,69
Fixed Assets Turnover	3,56	33,67	116,73	236,44	267,46
Receivables Turnover (Average Receivables)	-	-	87,83	117,98	112,52
Inventory Turnover (Average Inventory)	0,16	0,55	1,17	1,28	0,98
Kortfristig likviditet
Current Ratio	3,51	9,41	2,68	4,09	7,7
Quick Ratio	3,15	7,1	1,8	2,48	5,63
Operating Cash Flow to Current Liabilities	−1,86	−8,3	−1,54	−0,71	0,37
Days Sales Outstanding (Average Receivables)	-	-	4,16	3,1	3,24
Days Outstanding Inventory (Average Inventory)	2,29 tn	662,57	312,83	285,14	374,12
Average Days Payable Outstanding	682,9	25,17	16,46	11,28	49,68
Cash Conversion Cycle (Average Days)	-	-	300,52	276,97	327,69
Långsiktig solvens
Total Debt/Equity	0,01	0,55	0,75	0,14	11,29
Total Debt / Total Capital	0,01	0,54	0,75	0,14	10,14
LT Debt/Equity	-	0,32	0,25	-	11,29
Long-Term Debt / Total Capital	-	0,32	0,25	-	10,14
Total Liabilities / Total Assets	28,34	10,77	36,8	24,17	21,72
EBIT / Interest Expense	−575,38	−3,13 tn	-	−178,14	−418,33
EBITDA / Interest Expense	−572,08	−3,12 tn	-	−173,14	−404,33
(EBITDA - Capex) / Interest Expense	−575,23	−3,13 tn	-	−175,29	−409,67
Total Debt / EBITDA	−0	−0,01	−0,01	−0,01	−0,77
Net Debt / EBITDA	1,49	0,79	1,02	4,12	4,75
Total Debt / (EBITDA - Capex)	−0	−0,01	−0,01	−0,01	−0,76
Net Debt / (EBITDA - Capex)	1,48	0,79	1,01	4,07	4,68
Tillväxt jämfört med föregående år
Total Revenues, 1 Yr. Growth %	2,35 tn	1,21 tn	433,68	115,55	−9,6
Gross Profit, 1 Yr. Growth %	3,93 tn	1,64 tn	468,49	118,63	−8,62
EBITDA, 1 Yr. Growth %	58,74	−16,22	−39,5	−67,85	0,08
EBITA, 1 Yr. Growth %	58,31	−16,23	−39,31	−67,21	0,64
EBIT, 1 Yr. Growth %	58,31	−16,23	−39,31	−67,21	0,64
Earnings From Cont. Operations, 1 Yr. Growth %	1,39	−61,46	9,23	−93,83	30,15
Net Income, 1 Yr. Growth %	0,94	−62,54	24,87	−60,98	−38,71
Normalized Net Income, 1 Yr. Growth %	0,68	−63,2	28,99	−66,45	−45,01
Diluted EPS Before Extra, 1 Yr. Growth %	−27,16	−66,21	20,96	−64,19	−41,02
Accounts Receivable, 1 Yr. Growth %	-	-	301,61	0,4	−10,8
Inventory, 1 Yr. Growth %	18,6	121,76	54,46	89,87	−34,31
Net Property, Plant and Equip., 1 Yr. Growth %	−3,57	81,48	38,78	−16,91	−23,89
Total Assets, 1 Yr. Growth %	190,15	−44,52	−0,52	33,43	13,63
Tangible Book Value, 1 Yr. Growth %	−351,04	−29,39	−35,83	25,93	8,36
Common Equity, 1 Yr. Growth %	−351,04	−29,39	−35,83	25,93	8,36
Cash From Operations, 1 Yr. Growth %	79,79	−8,48	−35,65	−59,55	−131,35
Capital Expenditures, 1 Yr. Growth %	-	−36,59	76,92	−67,39	6,67
Levered Free Cash Flow, 1 Yr. Growth %	−284,93	−15,68	−88,47	−69,47	−201,82
Unlevered Free Cash Flow, 1 Yr. Growth %	−284,5	−15,61	−88,47	−70,08	−204,76
Sammansatt Årlig Tillväxthastighet Över Två År
Total Revenues, 2 Yr. CAGR %	-	1,69 tn	734,74	239,17	39,59
Gross Profit, 2 Yr. CAGR %	-	2,55 tn	894,95	252,54	41,35
EBITDA, 2 Yr. CAGR %	58,03	15,33	−28,8	−55,9	−43,28
EBITA, 2 Yr. CAGR %	57,88	15,16	−28,7	−55,39	−42,55
EBIT, 2 Yr. CAGR %	57,88	15,16	−28,7	−55,39	−42,55
Earnings From Cont. Operations, 2 Yr. CAGR %	73,95	−37,49	−35,12	−74,04	−71,67
Net Income, 2 Yr. CAGR %	73,57	−38,5	−31,6	−30,2	−51,1
Normalized Net Income, 2 Yr. CAGR %	73,34	−39,13	−31,1	−34,21	−57,04
Diluted EPS Before Extra, 2 Yr. CAGR %	27,23	−50,39	−36,07	−34,19	−54,04
Accounts Receivable, 2 Yr. CAGR %	-	456,78	-	100,8	−5,36
Inventory, 2 Yr. CAGR %	-	62,18	85,08	71,25	11,68
Net Property, Plant and Equip., 2 Yr. CAGR %	−24,61	32,29	58,7	7,38	−20,48
Total Assets, 2 Yr. CAGR %	120,69	26,87	−25,71	15,21	23,13
Tangible Book Value, 2 Yr. CAGR %	153,15	33,14	−32,69	−10,11	16,82
Common Equity, 2 Yr. CAGR %	153,15	33,14	−32,69	−10,11	16,82
Cash From Operations, 2 Yr. CAGR %	56,26	28,28	−23,26	−48,98	−64,39
Capital Expenditures, 2 Yr. CAGR %	113,44	-	5,92	−24,04	−41,02
Levered Free Cash Flow, 2 Yr. CAGR %	176,69	24,86	−68,83	−81,24	−44,25
Unlevered Free Cash Flow, 2 Yr. CAGR %	180,19	24,77	−68,81	−81,43	−44,02
Treårig Sammansatt Årlig Tillväxthastighet
Total Revenues, 3 Yr. CAGR %	-	-	1,1 tn	431,55	118,27
Gross Profit, 3 Yr. CAGR %	-	-	1,49 tn	500,39	124,78
EBITDA, 3 Yr. CAGR %	-	27,9	−6,99	−45,38	−42,04
EBITA, 3 Yr. CAGR %	55,25	27,81	−6,98	−44,96	−41,49
EBIT, 3 Yr. CAGR %	55,25	27,81	−6,98	−44,96	−41,49
Earnings From Cont. Operations, 3 Yr. CAGR %	70,29	5,26	−24,71	−70,39	−55,57
Net Income, 3 Yr. CAGR %	70,04	4,12	−22,13	−43,27	−33,16
Normalized Net Income, 3 Yr. CAGR %	69,89	3,41	−21,81	−45,79	−38,03
Diluted EPS Before Extra, 3 Yr. CAGR %	22,75	−18,22	−33,23	−47,3	−36,55
Accounts Receivable, 3 Yr. CAGR %	-	-	399,33	-	53,22
Inventory, 3 Yr. CAGR %	-	-	59,57	86,66	24,43
Net Property, Plant and Equip., 3 Yr. CAGR %	162,07	1,04	34,42	27,91	−4,26
Total Assets, 3 Yr. CAGR %	167,09	39,28	16,99	−9,7	14,68
Tangible Book Value, 3 Yr. CAGR %	314,66	65,4	4,39	−17,06	−4,33
Common Equity, 3 Yr. CAGR %	314,66	65,4	4,39	−17,06	−4,33
Cash From Operations, 3 Yr. CAGR %	62,03	30,74	1,92	−38,01	−56,63
Capital Expenditures, 3 Yr. CAGR %	99,77	42,42	-	−28,48	−14,94
Levered Free Cash Flow, 3 Yr. CAGR %	-	86,19	−43,57	−69,04	−67,03
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	87,81	−43,59	−69,24	−66,94
Sammansatt Årlig Tillväxthastighet Över Fem År
Total Revenues, 5 Yr. CAGR %	-	-	-	-	406,29
Gross Profit, 5 Yr. CAGR %	-	-	-	-	503,07
EBITDA, 5 Yr. CAGR %	-	-	-	−16,46	−23,68
EBITA, 5 Yr. CAGR %	-	-	13,73	−16,11	−23,29
EBIT, 5 Yr. CAGR %	-	-	13,73	−16,11	−23,29
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	15,76	−39,88	−49,07
Net Income, 5 Yr. CAGR %	-	-	18,13	−11,27	−35,35
Normalized Net Income, 5 Yr. CAGR %	-	-	18,41	−13,7	−38,47
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	−5,44	−25,02	−42,5
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	156,72
Inventory, 5 Yr. CAGR %	-	-	-	-	38,34
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	114,43	3,53	8,96
Total Assets, 5 Yr. CAGR %	-	-	60,09	29,1	19,41
Tangible Book Value, 5 Yr. CAGR %	-	-	100,38	29,6	9,19
Common Equity, 5 Yr. CAGR %	-	-	100,38	29,6	9,19
Cash From Operations, 5 Yr. CAGR %	-	-	20,16	−10,27	−33,08
Capital Expenditures, 5 Yr. CAGR %	-	-	54,99	10,76	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	−25,66	−43,84
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	−25,57	−43,76